Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dimebon

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Out of the shadows - Living with dementia

memory impairment2 - mid-life stress1 - menopause1 - invisible disease1 - dbs1 - nilotinib1 - dementia of lewy body1 - cajal-retzius cell1 - beta amyloid protein1 - symptomatic benefit1 - aortic valve stenosis2 - dementia friends1 - brain health1 - miller fisher1 - huntington's disease8 - neurodegeneration2 - adam10 enzyme1 - parkinson's7 - glucose hypometabolism1 - moderate dementia1 - calmeil1 - care or dementia1 - imbecility1 - alzheimer's society2 - sporadic parkinson's disease1 - p-tau1 - apoe genotype1 - amyloid hypothesis1 - hypertensive1 - age-related cognitive disorders1 -